Home/Filings/4/0001209191-20-009040
4//SEC Filing

Levy Howard 4

Accession 0001209191-20-009040

CIK 0001124105other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:28 PM ET

Size

5.5 KB

Accession

0001209191-20-009040

Insider Transaction Report

Form 4
Period: 2020-02-10
Levy Howard
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-02-10$6.23/sh+1,358$8,4601,358 total
Holdings
  • Common Stock

    (indirect: By Trust)
    16,094
Footnotes (1)
  • [F1]Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 10, 2020.

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001672333

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 8:28 PM ET
Size
5.5 KB